Interpharm Holdings, Inc. Stock

Stocks

IPAH

US4605881063

Pharmaceuticals

OTC Markets Traded
Market Closed - 15:26:41 2023-06-14 EDT 5-day change 1st Jan Change
0.001000 USD +900.00% Intraday chart for Interpharm Holdings, Inc. +99,900.00% +99,900.00%
1 week+99,900.00%
Current month+99,900.00%

Valuation: Interpharm Holdings, Inc.

Market Cap 1.07M 958K 875K 799K 1.51M 100M 1.55M 10.55M 4.21M 53.56M 4.01M 3.92M 169M P/E 2006
-9.26x
P/E 2007 -4.96x
Enterprise Value 27.54M 24.7M 22.57M 20.61M 38.83M 2.59B 40.05M 272M 109M 1.38B 103M 101M 4.36B EV / Sales 2006
1.63x
EV / Sales 2007 1.47x
Free-Float
100%
Yield 2006 *
-
Yield 2007 -
1 day+900.00%
1 week+99,900.00%
Current month+99,900.00%
1 month+99,900.00%
3 months+99,900.00%
6 months+99,900.00%
Current year+99,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.01
10 years 0
Extreme 1.0E-6
0.02
Change 5-day change 1-year change 3-year change Capi.($)
+900.00%+99,900.00%+99,900.00%+99,900.00% 66
-0.79%-4.48%+46.48%+118.69% 1,206B
+1.43%+1.11%+48.05%+83.72% 665B
+1.07%-1.21%+32.92%+105.10% 515B
+1.17%-0.81%+41.27%+65.48% 381B
-0.14%-1.87%+70.06%+40.55% 362B
+0.66%+1.69%+30.86%+58.65% 307B
+0.96%+1.13%+6.78%+34.30% 289B
+0.03%-1.20%+43.79%+68.49% 249B
-0.41%-2.22%+40.43%+114.24% 207B
Average +90.40%-1.38%+10,026.06%+10,058.92% 417.97B
Weighted average by Cap. +0.32%-1.96%+42.28%+86.40%

Financials

2006 2007
Net sales 63.36M 56.82M 51.93M 47.41M 89.32M 5.96B 92.13M 626M 250M 3.18B 238M 233M 10.03B 75.59M 67.79M 61.96M 56.56M 107M 7.11B 110M 747M 298M 3.79B 284M 278M 11.97B
Net income -3.79M -3.4M -3.11M -2.84M -5.34M -356M -5.51M -37.45M -14.93M -190M -14.23M -13.92M -600M -14.06M -12.61M -11.52M -10.52M -19.82M -1.32B -20.44M -139M -55.38M -705M -52.77M -51.64M -2.23B
Net Debt 14.2M 12.74M 11.64M 10.63M 20.02M 1.33B 20.65M 140M 55.94M 712M 53.3M 52.16M 2.25B 26.47M 23.74M 21.7M 19.81M 37.32M 2.49B 38.5M 262M 104M 1.33B 99.37M 97.24M 4.19B
Logo Interpharm Holdings, Inc.
Interpharm Holdings, Inc., through its wholly owned subsidiary, Interpharm, Inc., is engaged in the business of developing, manufacturing and marketing generic prescription strength and over-the-counter pharmaceuticals. The Company sells its products under its own label to the major retailers, wholesalers, managed care organizations and national distributors, and under private label to wholesalers, distributors, repackagers and other manufacturers. During the fiscal year ended June 30, 2007 (fiscal 2007), the Company manufactured and marketed 36 generic pharmaceutical products, which represent various oral dosage strengths for 11 products and different dosage strengths for 25 of these products.
Employees
670
  1. Stock Market
  2. Stocks
  3. IPAH Stock